Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Sectors and research

Diagnostics companies

Healthcare is more than just medicines and vaccines: diagnostics are also essential for treating and managing disease. With better access to diagnostic and monitoring technology, quality of life is improved and avoidable deaths are reduced. We engage diagnostics companies to increase access to life-changing products in low- and middle-income countries.
Event

Ensuring access to health innovation for all: Jayasree K. Iyer to speak at the Milken Institute Global Conference

02 May 2022
News

Taking access to the next level: mobilising five essential healthcare sectors

14 December 2021
Event

CEPI Global Pandemic Preparedness Summit

08 March 2022
Featured Event

Jayasree K. Iyer to speak at the World Economic Forum Annual Meeting 2022 on strengthening health systems and mitigating future shocks

23 May 2022

Lack of access to diagnostics costs lives

Diagnostics and monitoring devices are an essential element of the health system and a critical part of the continuum of care. Whether performed on blood, tissue or other patient samples, diagnostic tests are a vital source of information for healthcare providers and patients. They help determine which treatments are needed and can be used to monitor and manage disease. 

In developed markets, diagnostics form an integral part of decision-making at every step along the care pathway. However, in low- and middle-income countries, diagnosis remains one of the weakest links in the care cascade, leading to unnecessary suffering and deaths. This discrepancy became abundantly clear in the COVID-19 pandemic, with high-income countries having testing rates for SARS-CoV-2 ten times higher than low- and middle-income countries.

The diagnostics sector is highly fragmented, and there is a lack of joined-up strategy for improving the availability of diagnostics in lower-income countries. This results in gaps in supply and access across multiple therapeutic areas, including infectious diseases, maternal and neonatal health, and noncommunicable diseases such as diabetes and cardiovascular disease.

It is time to realise the potential of diagnostics for global health

Diagnostics companies play a critical role in providing patients with a comprehensive spectrum of care. In many therapeutic areas, such companies hold the key to increasing access to scientific innovation in low- and middle-income countries.

There are four key areas where diagnostics companies can step up to improve access to medicine:

  • Invest in global health R&D to adapt existing technologies to the needs of low- and middle-income countries and plan ahead for access to new technologies

  • Secure manufacturing capacity and quality at multiple global sites to ensure supply

  • Prioritise underserved populations and ensure diagnostics are available to all, from large organisations to individuals paying out-of-pocket

  • Facilitate diagnostic capacity building by supporting local experts in the use and maintenance of equipment

How we work to improve access to diagnostics

At the Access to Medicine Foundation, we work to incentivise diagnostics companies to do more to make their technologies and products available for people living in low- and middle-income countries. We have been engaging with several diagnostics companies for a number of years already in the context of our Access to Medicine Index and are currently expanding our work in this sector.

Resource center

Explore our research reports and publications.

Read more

We engage strategically in the diagnostics space to deliver the maximum impact. Although the diagnostics sector is fragmented overall, several important therapeutic areas are dominated by a few key players. This provides an opportunity to apply our tried-and-tested model to spur large companies to make steps towards improved access.

Read more about how we drive change

By forging constructive partnerships with local and global players, we can unlock the potential of diagnostics for all.

Johann Kolstee

Research Programme Manager

Get in touch

Explore our research sectors

Big pharma

We influence and encourage them to make their products accessible for all.

Discover more

Generic medicine manufacturers

We empower the industry to become more responsive

Discover more

Medical gas companies

We stimulate the industry to ensure availability for treatments and procedures.

Discover more

Diagnostic companies

We forge partnerships to unlock the potential of diagnostics.

Discover more

Vaccine manufacturers

We guide them to improve access to immunisation.

Discover more

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved